Type text, add images, blackout confidential details, add comments, highlights and more.
02. Sign it in a few clicks
Draw your signature, type it, upload its image, or use your mobile device as a signature pad.
03. Share your form with others
Send form 1572 via email, link, or fax. You can also download it, export it or print it out.
How to use or fill out FDA 1572 with our platform
Ease of Setup
DocHub User Ratings on G2
Ease of Use
DocHub User Ratings on G2
Click ‘Get Form’ to open the FDA 1572 in the editor.
Begin by filling in your name and address in Section 1. Ensure that all details are accurate, as this identifies you as the clinical investigator.
In Section 2, provide your education, training, and experience. You can upload your curriculum vitae or another statement of qualifications directly through our platform.
For Sections 3 and 4, enter the names and addresses of the medical school or research facility and any clinical laboratory facilities involved in the study.
Complete Section 5 by providing the name and address of the Institutional Review Board (IRB) responsible for approving your study.
In Section 6, list any sub-investigators. If none, simply enter 'None'.
Fill out Section 8 with a detailed outline of your clinical protocol information based on the phase of investigation.
Finally, review all sections for accuracy, sign and date at the bottom before forwarding it to your sponsor as instructed.
Start using our platform today to streamline your FDA 1572 form completion for free!
FDA 1572 Form PDFFDA 1572 templateFDA 1572 instructionsFDA 1572 guidance 2024FDA 1572 form 2025FDA 1572 FAQFDA 1572 update requirementsFDA 1572 Form europe
Security and compliance
At DocHub, your data security is our priority. We follow HIPAA, SOC2, GDPR, and other standards, so you can work on your documents with confidence.
Guidance on Statement of Investigator (Form FDA 1572)
The 1572 form is required for industry- initiated trials and PI-initiated trials that are multicenter. A 1572 form is also required for investigator-held INDRead more
Prostate Cancer Early Detection - Urology Guidelines
Mar 6, 2024 The FDA has approved the PCA3 assay to help decide, along with other factors, whether a repeat biopsy in individuals aged 50 years with one or.Read more
Cookie consent notice
This site uses cookies to enhance site navigation and personalize your experience.
By using this site you agree to our use of cookies as described in our Privacy Notice.
You can modify your selections by visiting our Cookie and Advertising Notice.